wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30402667-07E5F9CB-0420-4E9E-AA40-5B22621E8D0B
Q30402667-07E5F9CB-0420-4E9E-AA40-5B22621E8D0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30402667-07E5F9CB-0420-4E9E-AA40-5B22621E8D0B
Proteomics and biomarkers in clinical trials for drug development
P2860
Q30402667-07E5F9CB-0420-4E9E-AA40-5B22621E8D0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30402667-07E5F9CB-0420-4E9E-AA40-5B22621E8D0B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
baa4c7ef8166de71c52161867e1316fbd1386f80
P2860
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy.